$CERS
CERUS CORP

2016 Q2 Form 10-Q Financial Statement

#000156459016022970 Filed on August 05, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q2
Revenue $9.251M $8.830M
YoY Change 4.77% 2.66%
Cost Of Revenue $4.976M $7.028M
YoY Change -29.2% 47.9%
Gross Profit $4.275M $1.802M
YoY Change 137.24% -53.18%
Gross Profit Margin 46.21% 20.41%
Selling, General & Admin $12.41M $12.06M
YoY Change 2.84% 19.67%
% of Gross Profit 290.2% 669.42%
Research & Development $8.557M $5.213M
YoY Change 64.15% 10.4%
% of Gross Profit 200.16% 289.29%
Depreciation & Amortization $480.0K $400.0K
YoY Change 20.0% 37.93%
% of Gross Profit 11.23% 22.2%
Operating Expenses $21.01M $17.33M
YoY Change 21.28% 16.66%
Operating Profit -$16.74M -$15.53M
YoY Change 7.82% 41.09%
Interest Expense $658.0K $301.0K
YoY Change 118.6% 785.29%
% of Operating Profit
Other Income/Expense, Net -$444.0K -$2.482M
YoY Change -82.11% -171.75%
Pretax Income -$17.18M -$18.01M
YoY Change -4.58% 138.66%
Income Tax $983.0K -$2.035M
% Of Pretax Income
Net Earnings -$18.17M -$15.97M
YoY Change 13.74% 110.46%
Net Earnings / Revenue -196.37% -180.88%
Basic Earnings Per Share -$0.18 -$0.17
Diluted Earnings Per Share -$0.18 -$0.17
COMMON SHARES
Basic Shares Outstanding 101.6M 95.73M shares
Diluted Shares Outstanding 95.73M shares

Balance Sheet

Concept 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $84.05M $110.9M
YoY Change -24.22% 123.16%
Cash & Equivalents $7.704M $35.06M
Short-Term Investments $76.35M $75.85M
Other Short-Term Assets $5.345M $1.411M
YoY Change 278.81% -0.35%
Inventory $12.11M $13.68M
Prepaid Expenses $1.066M $1.009M
Receivables $5.149M $5.425M
Other Receivables $0.00 $0.00
Total Short-Term Assets $112.2M $144.5M
YoY Change -22.33% 105.45%
LONG-TERM ASSETS
Property, Plant & Equipment $3.216M $3.816M
YoY Change -15.72% 5.56%
Goodwill $1.316M $1.316M
YoY Change 0.0% 0.0%
Intangibles $1.041M
YoY Change -16.25%
Long-Term Investments
YoY Change
Other Assets $2.293M $140.0K
YoY Change 1537.86% 174.51%
Total Long-Term Assets $8.239M $6.935M
YoY Change 18.8% 6.17%
TOTAL ASSETS
Total Short-Term Assets $112.2M $144.5M
Total Long-Term Assets $8.239M $6.935M
Total Assets $120.5M $151.4M
YoY Change -20.45% 97.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.190M $5.765M
YoY Change 24.72% 81.92%
Accrued Expenses $9.439M $6.914M
YoY Change 36.52% -34.89%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $6.100M $2.500M
YoY Change 144.0%
Total Short-Term Liabilities $25.70M $22.22M
YoY Change 15.64% 2.38%
LONG-TERM LIABILITIES
Long-Term Debt $13.70M $17.40M
YoY Change -21.26% 77.55%
Other Long-Term Liabilities $1.356M $1.160M
YoY Change 16.9% 17.53%
Total Long-Term Liabilities $1.356M $1.160M
YoY Change 16.9% 17.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.70M $22.22M
Total Long-Term Liabilities $1.356M $1.160M
Total Liabilities $45.81M $40.88M
YoY Change 12.07% 25.22%
SHAREHOLDERS EQUITY
Retained Earnings -$567.4M
YoY Change 11.03%
Common Stock $670.4M
YoY Change 905878.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $74.60M $110.5M
YoY Change
Total Liabilities & Shareholders Equity $120.5M $151.4M
YoY Change -20.41% 97.01%

Cashflow Statement

Concept 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income -$18.17M -$15.97M
YoY Change 13.74% 110.46%
Depreciation, Depletion And Amortization $480.0K $400.0K
YoY Change 20.0% 37.93%
Cash From Operating Activities -$14.53M -$14.73M
YoY Change -1.36% 53.28%
INVESTING ACTIVITIES
Capital Expenditures -$80.00K -$270.0K
YoY Change -70.37% -54.24%
Acquisitions
YoY Change
Other Investing Activities -$5.980M $17.89M
YoY Change -133.43% 502.36%
Cash From Investing Activities -$6.050M $17.61M
YoY Change -134.36% 639.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.520M 14.24M
YoY Change -47.19% 20.58%
NET CHANGE
Cash From Operating Activities -14.53M -14.73M
Cash From Investing Activities -6.050M 17.61M
Cash From Financing Activities 7.520M 14.24M
Net Change In Cash -13.06M 17.12M
YoY Change -176.29% 273.8%
FREE CASH FLOW
Cash From Operating Activities -$14.53M -$14.73M
Capital Expenditures -$80.00K -$270.0K
Free Cash Flow -$14.45M -$14.46M
YoY Change -0.07% 60.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7704000
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
102709344
CY2015Q4 us-gaap Inventory Net
InventoryNet
10812000
CY2015Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
25698000
CY2016Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1066000
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1166000
CY2016Q2 us-gaap Other Assets Current
OtherAssetsCurrent
5345000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
112212000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3216000
CY2016Q2 us-gaap Goodwill
Goodwill
1316000
CY2016Q2 us-gaap Gross Profit
GrossProfit
4275000
CY2015Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
5213000
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12063000
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
51000
CY2015Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
51000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
21014000
CY2015Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2707000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3589000
CY2016Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
101000
CY2015Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
499000
CY2016Q2 us-gaap Interest Expense
InterestExpense
658000
CY2015Q2 us-gaap Interest Expense
InterestExpense
301000
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
113000
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27000
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-444000
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2482000
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2016Q2 us-gaap Available For Sale Securities Equity Securities Current
AvailableForSaleSecuritiesEquitySecuritiesCurrent
4487000
CY2015Q4 us-gaap Available For Sale Securities Equity Securities Current
AvailableForSaleSecuritiesEquitySecuritiesCurrent
11163000
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4755000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
130406000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3549000
CY2015Q4 us-gaap Goodwill
Goodwill
1316000
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
940000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
612000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2579000
CY2015Q4 us-gaap Assets
Assets
139402000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5217000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9853000
CY2015Q4 cers Accrual For Manufacturing And Development Payment Liability Current
AccrualForManufacturingAndDevelopmentPaymentLiabilityCurrent
3282000
CY2016Q2 us-gaap Secured Debt Current
SecuredDebtCurrent
6127000
CY2016Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
140000
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
122000
CY2016Q2 cers Accrual For Manufacturing And Development Payment Liability Noncurrent
AccrualForManufacturingAndDevelopmentPaymentLiabilityNoncurrent
4844000
CY2015Q4 cers Accrual For Manufacturing And Development Payment Liability Noncurrent
AccrualForManufacturingAndDevelopmentPaymentLiabilityNoncurrent
4542000
CY2016Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1356000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1263000
CY2016Q2 us-gaap Liabilities
Liabilities
45810000
CY2015Q4 us-gaap Liabilities
Liabilities
44637000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-16739000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
17327000
us-gaap Operating Expenses
OperatingExpenses
39728000
CY2016Q2 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
7000000
cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
9400000
us-gaap Operating Expenses
OperatingExpenses
34676000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15525000
us-gaap Operating Income Loss
OperatingIncomeLoss
-32084000
us-gaap Net Income Loss
NetIncomeLoss
-25432000
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Net Income Loss
NetIncomeLoss
-35029000
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27448000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1795000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101563000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5794000
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
839000
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
575000
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2293000
CY2016Q2 us-gaap Assets
Assets
120451000
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
7190000
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9439000
CY2016Q2 cers Accrual For Manufacturing And Development Payment Liability Current
AccrualForManufacturingAndDevelopmentPaymentLiabilityCurrent
2221000
CY2016Q2 us-gaap Inventory Net
InventoryNet
12111000
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5149000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71018000
CY2016Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
76350000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
85049000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
85000000
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3187000
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7625000
CY2016Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
8557000
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12406000
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
101000
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9251000
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
8830000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
16883000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
16522000
CY2016Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4976000
CY2015Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7028000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
9239000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
11742000
CY2015Q2 us-gaap Gross Profit
GrossProfit
1802000
us-gaap Gross Profit
GrossProfit
7644000
us-gaap Gross Profit
GrossProfit
4780000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
15474000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
10794000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24153000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23781000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
101000
us-gaap Operating Income Loss
OperatingIncomeLoss
-29896000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-16000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-614000
us-gaap Interest Expense
InterestExpense
1313000
us-gaap Interest Expense
InterestExpense
556000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
179000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1150000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2448000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33234000
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2015Q2 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2016Q2 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
CY2015Q2 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
CY2015Q2 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4311000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
7512000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39340000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17920000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-2263000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
4552000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17183000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18007000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-739000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1902000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4176000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-458000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1538000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
983000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2035000
cers Increase Decrease In Manufacturing And Development Payment Liability
IncreaseDecreaseInManufacturingAndDevelopmentPaymentLiability
-1082000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
189000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
256000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-27567000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-30484000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
118000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
325000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
70560000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
10000000
CY2016Q2 cers Accrued Leasehold Improvements Current And Accrued Leasehold Improvements Noncurrent
AccruedLeaseholdImprovementsCurrentAndAccruedLeaseholdImprovementsNoncurrent
400000
cers Non Cash Interest Expense
NonCashInterestExpense
603000
cers Non Cash Interest Expense
NonCashInterestExpense
139000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7000
cers Non Cash Tax Expense Benefit From Other Unrealized Gain Loss On Available For Sale Securities
NonCashTaxExpenseBenefitFromOtherUnrealizedGainLossOnAvailableForSaleSecurities
1702000
cers Non Cash Tax Expense Benefit From Other Unrealized Gain Loss On Available For Sale Securities
NonCashTaxExpenseBenefitFromOtherUnrealizedGainLossOnAvailableForSaleSecurities
-2085000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-645000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-69000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1318000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1112000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-435000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
69983000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
19500000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
22444000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-37000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
114000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-51141000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-47978000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
907000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5472000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14547000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
75324000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2016000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-18166000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-15972000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
95682000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8479000
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-205000
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
4552000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
964000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
835000
us-gaap Share Based Compensation
ShareBasedCompensation
3862000
us-gaap Share Based Compensation
ShareBasedCompensation
3179000
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17000000
us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<div> <p style="text-align:justify;margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Guarantee and Indemnification Arrangements</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company&#8217;s technology infringes the intellectual property rights of a third party or claims that the sale or use of the Company&#8217;s products have caused personal injury or other damage or loss. The Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company generally provides for a one-year warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims become known and are estimable. The Company has not experienced significant or systemic warranty claims nor is it aware of any existing current warranty claims. Accordingly, the Company had not accrued for any future warranty costs for its products at June 30, 2016 and December 31, 2015.</p></div>
CY2016Q2 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
3
CY2015Q4 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
3
cers Inventory Life Finished Goods Period
InventoryLifeFinishedGoodsPeriod
P2Y
cers Work In Process Inventory Life Period
WorkInProcessInventoryLifePeriod
P1Y
CY2016Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1600000
CY2015Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1800000
CY2016Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2015Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Dilutive Securities
DilutiveSecurities
-3589000
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-18166000
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-15972000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-35029000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-29021000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1106000
CY2016Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
CY2015Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
cers Product Warranty Term
ProductWarrantyTerm
P1Y
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
60000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
56000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
15394000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
90740000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-63314000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12278000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22781000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35059000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, which are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p></div>
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, available-for-sale securities and accounts receivable.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the Company&#8217;s investment policy, substantially all of the Company&#8217;s cash, cash equivalents and available-for-sale securities are maintained at major financial institutions of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company&#8217;s investments carry high credit quality ratings, which is in accordance with its investment policy. At June 30, 2016, the fair value of the Company&#8217;s marketable equity securities of Aduro is subject to the underlying volatility of Aduro&#8217;s stock price. At June 30, 2016, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company&#8217;s cash equivalents and short-term investments.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of credit risk with respect to trade receivables exist. On a regular basis, including at the time of sale, the Company performs credit evaluations of its significant customers that it expects to sell to on credit terms. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company establishes an allowance for doubtful accounts against the accounts receivable on its unaudited condensed consolidated balance sheets and records a charge on its unaudited condensed consolidated statements of operations as a component of selling, general and administrative expenses.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company had three customers that accounted for more than 10% of the Company&#8217;s outstanding trade receivables at June 30, 2016 and December&#160;31, 2015. These customers cumulatively represented approximately 37% and 49% of the Company&#8217;s outstanding trade receivables at June 30, 2016 and December&#160;31, 2015, respectively. To date, the Company has not experienced collection difficulties from these customers.</p></div>
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2016Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
12000
CY2016Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
20114000
CY2016Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2017000
CY2016Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1178000
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2017000
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1077000
CY2016Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2016Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
12000
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
20170000
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
46000
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
49000
CY2016Q2 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2016Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3354000
CY2016Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8757000
CY2016Q2 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
5528000
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
3000
CY2015Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
25698000
CY2015Q4 us-gaap Available For Sale Equity Securities Amortized Cost Basis
AvailableForSaleEquitySecuritiesAmortizedCostBasis
0
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
10111000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
66311000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
10144000
CY2016Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
20114000
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P10Y
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16531000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15759000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13102000
CY2016Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
80942000
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
96163000
CY2016Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
76402000
CY2016Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4552000
CY2016Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
12000
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
85049000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
11163000
CY2015Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
49000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
66291000
CY2016Q2 us-gaap Available For Sale Equity Securities Amortized Cost Basis
AvailableForSaleEquitySecuritiesAmortizedCostBasis
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2015Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
100000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
200000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
200000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
200000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
100000
CY2016Q2 us-gaap Cost Method Investments
CostMethodInvestments
0
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5074000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5198000
CY2016Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3294000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2337000
CY2016Q2 cers Accrued Customer Costs Current
AccruedCustomerCostsCurrent
482000
CY2015Q4 cers Accrued Customer Costs Current
AccruedCustomerCostsCurrent
987000
CY2015Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
438000
CY2016Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
589000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
893000
CY2016Q2 cers Debt Instrument Carrying Current
DebtInstrumentCarryingCurrent
6208000
CY2016Q2 cers Debt Instrument Unamortized Current
DebtInstrumentUnamortizedCurrent
81000
CY2016Q2 cers Debt Instrument Carrying Non Current
DebtInstrumentCarryingNonCurrent
13792000
CY2016Q2 cers Debt Instrument Unamortized Noncurrent
DebtInstrumentUnamortizedNoncurrent
66000
CY2015Q4 cers Debt Instrument Carrying Current
DebtInstrumentCarryingCurrent
3050000
CY2015Q4 cers Debt Instrument Unamortized Current
DebtInstrumentUnamortizedCurrent
94000
CY2015Q4 cers Debt Instrument Carrying Non Current
DebtInstrumentCarryingNonCurrent
16950000
CY2015Q4 cers Debt Instrument Unamortized Noncurrent
DebtInstrumentUnamortizedNoncurrent
102000
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3050000
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6428000
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6892000
CY2016Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
3630000
CY2016Q2 us-gaap Long Term Debt
LongTermDebt
20000000
CY2016Q2 cers Longterm Debt Maturities Repayments Of Interest In Next Twelve Months
LongtermDebtMaturitiesRepaymentsOfInterestInNextTwelveMonths
654000
CY2016Q2 cers Long Term Debt Maturities Repayments Of Interest In Year Two
LongTermDebtMaturitiesRepaymentsOfInterestInYearTwo
980000
CY2016Q2 cers Long Term Debt Maturities Repayments Of Interest In Year Three
LongTermDebtMaturitiesRepaymentsOfInterestInYearThree
517000
CY2016Q2 cers Long Term Debt Maturities Repayments Of Interest In Year Four
LongTermDebtMaturitiesRepaymentsOfInterestInYearFour
1474000
CY2016Q2 cers Long Term Debt Maturities Repayments Of Interest
LongTermDebtMaturitiesRepaymentsOfInterest
3625000
CY2016Q2 cers Long Term Debt Maturities Repayments Of Principal And Interest In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInNextTwelveMonths
3704000
CY2016Q2 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearTwo
7408000
CY2016Q2 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearThree
7409000
CY2016Q2 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearFour
5104000
CY2016Q2 cers Long Term Debt Maturities Repayments Of Principal And Interest
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterest
23625000
cers Minimum Term Of Non Cancelable Operating Leases
MinimumTermOfNonCancelableOperatingLeases
P1Y
cers Expiration Of Non Cancelable Operating Leases Maximum Year
ExpirationOfNonCancelableOperatingLeasesMaximumYear
2020
CY2010 cers Proceeds From Landlord Financing Leasehold Improvement
ProceedsFromLandlordFinancingLeaseholdImprovement
1100000
CY2016Q2 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
3500000
CY2015Q2 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
4700000
CY2016Q2 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
900000
CY2015Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
200000

Files In Submission

Name View Source Status
0001564590-16-022970-index-headers.html Edgar Link pending
0001564590-16-022970-index.html Edgar Link pending
0001564590-16-022970.txt Edgar Link pending
0001564590-16-022970-xbrl.zip Edgar Link pending
cers-10q_20160630.htm Edgar Link pending
cers-20160630.xml Edgar Link completed
cers-20160630.xsd Edgar Link pending
cers-20160630_cal.xml Edgar Link unprocessable
cers-20160630_def.xml Edgar Link unprocessable
cers-20160630_lab.xml Edgar Link unprocessable
cers-20160630_pre.xml Edgar Link unprocessable
cers-ex311_8.htm Edgar Link pending
cers-ex312_6.htm Edgar Link pending
cers-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending